Court Finds Bayer’s Yasmin Oral Contraceptive Patent Is Invalid
This article was originally published in The Pink Sheet Daily
Executive Summary
A district court ruling against Bayer’s oral contraceptive patent opens the way for Barr to launch a generic version of Yasmin.
You may also be interested in...
Barr Gets Go-Ahead For Generic Yasmin
ANDA approval comes two months after court ruling on Bayer contraceptive.
Barr Gets Go-Ahead For Generic Yasmin
ANDA approval comes two months after court ruling on Bayer contraceptive.
Bayer Files Patent Infringement Suit Against Watson Over Yaz Generics
Watson follows Barr in filing ANDA paragraph IV certification against Yaz patent.